57
Views
0
CrossRef citations to date
0
Altmetric
Articles

Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions

ORCID Icon, , , , , , ORCID Icon & show all
Pages 743-749 | Received 26 May 2022, Accepted 18 Jul 2022, Published online: 23 Aug 2022

References

  • Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Sickle Cell Disease Clinical Research Network (SCDCRN), et al. Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial. Contemp Clin Trials. 2012;33(2):291–297. doi:10.1016/j.cct.2011.11.018.
  • Rule S, LeGouill S. Bureaucracy is strangling clinical research. BMJ. 2019;364:l1097. doi:10.1136/bmj.l1097.
  • Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation. J Natl Cancer Inst. 2019;111(3):245–255. doi:10.1093/jnci/djy221.
  • Castelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, et al. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology. ESMO Open. 2021;6(5):100237. doi:10.1016/j.esmoop.2021.100237.
  • Doherty GJ, Goksu M, de Paula BHR. Rethinking cancer clinical trials for COVID-19 and beyond. Nat Cancer. 2020;1(6):568–575. doi:10.1038/s43018-020-0083-x.
  • Marcum M, Kurtzweil N, Vollmer C, Schmid L, Vollmer A, Kastl A, et al. COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective. Cancer Med. 2020;9(17):6141–6146. doi:10.1002/cam4.3292.
  • Tuttle KR. Impact of the COVID-19 pandemic on clinical research. Nat Rev Nephrol. 2020;16(10):562–563. doi:10.1038/s41581-020-00336-9.
  • Burki TK. Cuts in cancer research funding due to COVID-19. Lancet Oncol. 2021;22(1):e6. doi:10.1016/S1470-2045(20)30749-X.
  • Lamont EB, Diamond SS, Katriel RG, Ensign LL, Liu J, Rusli E, Alexander GC. Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic. JAMA Netw Open. 2021;4(1):e2036353. doi:10.1001/jamanetworkopen.2020.36353.
  • Fleury ME, Farner AM, Unger JM. Association of the COVID-19 outbreak with patient willingness to enroll in cancer clinical trials. JAMA Oncol. 2021;7(1):131–132. doi:10.1001/jamaoncol.2020.5748.
  • Hennessy S, Bilker WB, Berlin JA, Strom BL. Factors Influencing the Optimal Control-to-Case Ratio in Matched Case-Control Studies. Am J Epidemiol. 1999;149(2):195–197. doi:10.1093/oxfordjournals.aje.a009786.
  • UK Coronavrisu Cancer Programme. 2022. https://ukcovidcancerprogramme.org/
  • Lee LYW, Starkey T, Ionescu MC, Little M, Tilby M, Tripathy AR, NCRI Consumer Forum, et al. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study. Lancet Oncol. 2022;23(6):748–757. doi:10.1016/S1470-2045(22)00202-9.
  • The COVID-19 and Cancer Consortium. 2022. https://ccc19.org/
  • Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data. 2022. https://www.scienceopen.com/document?vid=004ec3dd-b9b1-435d-b08b-80526c162e4e
  • Elkin ME, Zhu X. Understanding and predicting COVID-19 clinical trial completion vs. cessation. PLoS One. 2021;16(7):e0253789. doi:10.1371/journal.pone.0253789.
  • Prudencio M, Cosa JC. Research funding after COVID-19. Nat Microbiol. 2020;5(8):986.
  • Unger JM, Blanke CD, LeBlanc M, Hershman DL. Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials. JAMA Netw Open. 2020;3(6):e2010651. doi:10.1001/jamanetworkopen.2020.10651.
  • Estimated New Cancer Cases and Deaths for 2013. SEER Cancer Statistics Review 1975-2010. 2022. http://seer.cancer.gov/csr/1975_2010/browse_csr.php?sectionSEL=1&pageSEL=sect_01_table.01.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.